Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)
UK Biobank launches one of the largest scientific studies measuring circulating proteins, to better understand the link between genetics and human disease